Skip to main content
# Title Department Research Year
61 Development of oral formulation of Lepidium seeds significantly decreases the high blood glucose levels in diabetic rats: in vitro formulation and in vivo antidiabetic performance 2023
62 Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension Department of Industrial Pharmacy 2023
63 Effects of lidocaine derived organic compounds on eosinophil activation and survival 2023
64 Naturally occurring phenylethanoids and phenylpropanoids: antimalarial potential Department of Pharmacognosy 2023
65 Novel Drugs Obtained via Biotransformation—In Memory of the Late Scientists Frieder Schauer and Peter Grunwald 2023
66 Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper tetracyanoquinodimethane enhanced sensor Department of Pharmaceutical Analytical Chemistry 2023
67 New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
68 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM Department of Pharmacognosy 2023
69 Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain Department of Pharmaceutics 2023
70 Combined experimental/computational aspects for the molecular interaction of empagliflozin with bovine serum albumin: Quantification and application to human plasma Department of Medicinal Chemistry 2023